Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. Telso_Sopharma_EN_2025.07.21Buy.pdfNotification from "Telso" AD in accordance with Regulation 596/2014 for receival of shares from a capital increase of Sopharma

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 90 / 2025
Date of issue: 2025-07-22
Short name of the issuer
SOPHARMA AD
Subject
Notification from "Telso" AD in accordance with Regulation 596/2014 for receival of shares from a capital increase of Sopharma
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
Notification from "Telso" AD in accordance with Regulation 596/2014 for receival of shares from a capital increase of Sopharma
Annexes
File Description
Telso_Sopharma_EN_2025.07.21Buy.pdf
Telso_Sopharma_EN_2025.07.21Buy.pdf		 Notification from "Telso" AD in accordance with Regulation 596/2014 for receival of shares from a capital increase of Sopharma

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2025-07-22 Ognian Donev Executive director
20250722_152546_0459755653_Telso_Sopharma_EN_2025.07.21Buy.pdf

Pobierz